MedTrace Logo

Association Between Postoperative Administration of L-Arginine and CSA-AKI

NCT06248359 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2025-04-04

No results posted yet for this study

Summary

To investigate the association between the the early administration of L-Arginine after CPB-assisted cardiac surgery and the incidence of CS-AKI in adult patients. To test if it can reduce the incidence of post-operative AKI.

Conditions

Interventions

DRUG

L-Arginine hydrochloride

Postoperative administration of L-Arginine hydrochloride before incidence of CS-AKI

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Chong Lei · Xijing Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06248359 on ClinicalTrials.gov